Breast cancer drug 'may skew health budgets'
30th Nov 2005, 04:58 GMT
Society: Health authorities should think carefully about providing Herceptin because of its cost, academics warn.
Breast cancer drug 'may skew health budgets' related news:
- Breast cancer drug 'may skew health budgets' — Guardian Unlimited UK Latest
- Health boards warned to consider costs before offering cancer drug — Scotsman.com News - UK
- Warnings over cost of cancer drug — the Mail online | Health news
- Breast Cancer Drug Costs 'Could Double' Report Highlights Financial Burden of Using Herceptin — RedOrbit News - Health
- Novartis Warns About Breast Cancer Drug Use — NYNewsday.com Health and Science headlines
- Trusts 'can't afford breast cancer drug' — the Mail online | Health
- Will Herceptin be effective for early breast cancer? — Medical News Today RSS/XML Feed
- Cancer Drug Green Light — RedOrbit News - Health
- Warning issued for breast cancer drug — MSNBC.com: Health
- New breast cancer drug shows promise — The Cancer Blog
Latest news from Guardian Unlimited:
- Experts investigate boat blast
- Campaigners fear for lesbian facing deportation
- Fatah and Hamas poised to name PM
- Lebanon crisis grows as sixth minister quits
- Miliband: we can make progress on climate change
- Cold war part two
- Horse racing: Desert Orchid dies aged 27
- Doctor accused mother of killing son, hearing told
- ITV share price rises ahead of NTL talks
- Wangari Maathai: A billion trees can make a difference